[144] Artivion, Inc. SEC Filing
Artivion, Inc. (AORT) Form 144 notice reports proposed sale of 10,000 common shares by an insider via Morgan Stanley Smith Barney LLC, with an aggregate market value of $443,700 and an approximate sale date of 08/25/2025. The form shows those shares were acquired and paid for on 08/25/2025 through a stock option exercise with cash payment. The filing also discloses two recent common-stock sales by JEAN F HOLLOWAY: 23,356 shares sold on 08/12/2025 for $1,004,605.97 and 8,748 shares sold on 05/27/2025 for $253,692.00. The filer affirms no undisclosed material adverse information.
- Disclosure compliance: The filing provides required Rule 144 details including broker, share counts, market value, and sale date.
- Transaction transparency: The form states acquisition method (stock option exercise), payment method (cash), and exact acquisition and proposed sale dates.
- Insider sales occur: The filing records a proposed sale of 10,000 shares ($443,700) and recent insider sales totaling $1,258,297.97, which may be viewed negatively by some shareholders.
Insights
TL;DR: Insiders disclosed planned and recent sales totaling material dollar amounts, filed under Rule 144; transaction details are routine disclosures.
The Form 144 shows a proposed sale of 10,000 shares valued at $443,700 to be executed through Morgan Stanley Smith Barney LLC on 08/25/2025. The same filing documents prior sales by JEAN F HOLLOWAY totaling 31, and 104 shares? (Note: actual share totals are 23,356 and 8,748) for proceeds of $1,258,297.97 in the past three months. These are controlled, Rule 144 disclosures that provide transparency about insider liquidity but do not, by themselves, indicate operational changes. Investors can use the exact dates, amounts, and broker details to verify execution and timing against public market activity.
TL;DR: Filing documents insider stock option exercise followed by planned sale; disclosure meets Rule 144 requirements and includes seller attestation.
The document indicates the 10,000 shares were acquired via stock option exercise on the same date as the proposed sale and paid in cash, and that the seller attests to no undisclosed material adverse information. It also lists two recent sales by JEAN F HOLLOWAY with precise proceeds. From a governance perspective, the filing provides required transparency on insider transactions and includes the standard attestation language and broker details, supporting compliance with Section 144 procedures.